Drug Repositioning Service
Various
ServiceActive
Key Facts
About Biovista
Biovista is a private, AI-driven healthcare analytics company with a decade-long track record in drug repositioning and clinical de-risking. Its flagship platform, Vizit, leverages machine learning and natural language processing across multiple biomedical corpora to generate novel therapeutic hypotheses and optimize drug development. The company generates revenue by offering its AI platform and analytical services to pharmaceutical, generics, and life sciences companies, positioning itself as a partner for cost-effective therapy development and pipeline management. Its focus on human-in-the-loop AI and real-world application differentiates it from purely computational players.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| New TCM Formula Registration | Universe Pharmaceuticals | Development |
| CBD/THC Oil Formulation | Avecho Biotechnology | Preclinical |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |
| Companion Diagnostics Development | Kiffik Biomedical | Pre-clinical |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Portfolio of 40+ products | Praxgen Pharmaceuticals | Development |
| Custom Control Development | Anchor Molecular | Development/Commercial |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |
| Generic Medicinal Products Development | Basic Pharma | Commercial |